Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Entasis Therapeutics Holdings Inc. (ETTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/11/2022 |
SC 13D/A
| Innoviva, Inc. reports a 100% stake in ENTASIS THERAPEUTICS HOLDINGS INC. |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/11/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/11/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 07/11/2022 |
4
| Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 80,500 shares
@ $0
Disposed of 73,400 options to buy
@ $2.4, valued at
$176.2k
|
|
| 07/11/2022 |
4
| Triola Anna Diaz (Chief Commercial Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 125,000 shares
@ $0
Disposed of 100,000 options to buy
@ $2.49, valued at
$249k
|
|
| 07/11/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 39,596 shares
@ $2.2, valued at
$87.1k
Disposed/sold 150,000 shares
@ $0
Disposed of 98,700 options to buy
@ $2.44, valued at
$240.8k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
Disposed of 24,858 options to buy
@ $3.11, valued at
$77.3k
Disposed of 6,465 options to buy
@ $3.74, valued at
$24.2k
|
|
| 07/11/2022 |
4
| Ronsheim Matthew (Chief of Pharma Sciences & MFG) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 33,333 options to buy
@ $2.44, valued at
$81.3k
Disposed of 20,000 options to buy
@ $2.86, valued at
$57.2k
Disposed of 15,000 options to buy
@ $4.7, valued at
$70.5k
Disposed of 20,000 options to buy
@ $4.8, valued at
$96k
|
|
| 07/11/2022 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 56,072 shares
@ $2.2, valued at
$123.4k
Disposed/sold 478,500 shares
@ $0
Disposed of 325,755 options to buy
@ $2.44, valued at
$794.8k
Disposed of 145,000 options to buy
@ $4.94, valued at
$716.3k
Disposed of 183,013 options to buy
@ $3.11, valued at
$569.2k
Disposed of 69,970 options to buy
@ $3.74, valued at
$261.7k
|
|
| 07/11/2022 |
4
| Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,092 shares
@ $2.2, valued at
$37.6k
Disposed/sold 150,000 shares
@ $0
Disposed of 75,698 options to buy
@ $2.44, valued at
$184.7k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
Disposed of 25,092 options to buy
@ $3.11, valued at
$78k
Disposed of 18,253 options to buy
@ $3.74, valued at
$68.3k
|
|
| 07/11/2022 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 17,307 options to buy
@ $2.44, valued at
$42.2k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 12,500 options to buy
@ $2.44, valued at
$30.5k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 20,833 options to buy
@ $2.44, valued at
$50.8k
Disposed of 50,000 options to buy
@ $2.94, valued at
$147k
|
|
| 07/11/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 26,583 options to buy
@ $2.44, valued at
$64.9k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Berger Heather A. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 17,307 options to buy
@ $2.44, valued at
$42.2k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 92,307 options to buy
@ $2.44, valued at
$225.2k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
|
|
| 07/11/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/08/2022 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 07/08/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 07/08/2022 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
|
|
|